Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 65,846 | 71,360 | 44,755 | 30,858 | 49,569 |
| Cost of Goods | 8,830 | 6,905 | 5,503 | 3,464 | 3,256 |
| Gross Profit | 57,016 | 64,455 | 39,252 | 27,394 | 46,313 |
| Operating Expenses | 82,375 | 72,992 | 78,821 | 77,935 | 78,191 |
| Operating Income | -24,529 | -7,632 | -39,066 | -50,077 | -31,622 |
| Interest Expense | 2,982 | 5,551 | 6,653 | 7,484 | 7,480 |
| Other Income | 2,730 | 2,718 | 4,182 | 5,229 | 4,044 |
| Pre-tax Income | -24,781 | -10,465 | -41,537 | -52,332 | -35,058 |
| Income Tax | 279 | 323 | N/A | N/A | 324 |
| Net Income Continuous | -25,060 | -10,788 | -41,537 | -52,332 | -35,382 |
| Net Income | $-25,060 | $-10,788 | $-41,537 | $-52,332 | $-35,382 |
| EPS Basic Total Ops | -0.20 | -0.09 | -0.33 | -0.42 | -0.32 |
| EPS Basic Continuous Ops | -0.20 | -0.08 | -0.33 | -0.42 | -0.32 |
| EPS Diluted Total Ops | -0.20 | -0.09 | -0.33 | -0.42 | -0.32 |
| EPS Diluted Continuous Ops | -0.20 | -0.08 | -0.33 | -0.42 | -0.32 |
| EPS Diluted Before Non-Recurring Items | -0.20 | -0.09 | -0.33 | -0.42 | N/A |
| EBITDA(a) | $-22,409 | $-8,415 | $-39,487 | $-52,448 | $-32,989 |